Literature DB >> 19404279

Estimated glomerular filtration rate: time for a performance review?

Richard J Glassock1.   

Abstract

Measurement of the glomerular filtration rate (GFR) is an essential element in assessing renal function. Formulaic estimations of GFR (eGFRs) are widely used but have many pitfalls. Application of eGFR without adjustment for the effects of aging and gender results in overdiagnosis of chronic kidney disease (CKD). eGFR formulae also contain variables that independently influence the risk of CKD and cardiovascular disease. eGFR needs a performance review to foster its evolution as a clinically useful tool.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19404279     DOI： 10.1038/ki.2009.38

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  8 in total

1.  Kidney disease, hospitalized hypertension, and cardiovascular events: cause or consequence?

Authors:  Glenn M Chertow; Tara I Chang
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

2.  Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Lesley A Stevens; Suying Li; Changchun Wang; Cindy Huang; Bryan N Becker; Andrew S Bomback; Wendy Weinstock Brown; Nilka Ríos Burrows; Claudine T Jurkovitz; Samy I McFarlane; Keith C Norris; Michael Shlipak; Adam T Whaley-Connell; Shu-Cheng Chen; George L Bakris; Peter A McCullough
Journal:  Am J Kidney Dis       Date:  2010-03       Impact factor: 8.860

Review 3.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal:  Eur Radiol       Date:  2011-08-25       Impact factor: 5.315

Review 4.  GFR estimation: from physiology to public health.

Authors:  Andrew S Levey; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2014-01-28       Impact factor: 8.860

5.  Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.

Authors:  John M Lachin; Giancarlo Viberti; Bernard Zinman; Steven M Haffner; R Paul Aftring; Gitanjali Paul; Barbara G Kravitz; William H Herman; Rury R Holman; Steven E Kahn
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-31       Impact factor: 8.237

6.  Clinical Decision Making in a Patient with Stage 5 CKD--Is eGFR Good Enough?

Authors:  Jeffrey S Berns
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-16       Impact factor: 8.237

7.  Vitamin D3 repletion in chronic kidney disease stage 3: effects on blood endotoxin activity, inflammatory cytokines, and intestinal permeability.

Authors:  Manish P Ponda; Jan L Breslow
Journal:  Ren Fail       Date:  2013-03-18       Impact factor: 2.606

Review 8.  A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.

Authors:  Katherine T Mills; Yu Xu; Weidong Zhang; Joshua D Bundy; Chung-Shiuan Chen; Tanika N Kelly; Jing Chen; Jiang He
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.